Closure of Trading Window for the third quarter ending on 31 December 2025 for the financial year 2025-26.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sampre Nutritions Ltd has announced the closure of its trading window from 1 January 2026 until 48 hours after the declaration of unaudited financial results for the third quarter ending 31 December 2025. This is a standard insider trading compliance measure under SEBI regulations, restricting promoters, directors, designated persons, and their immediate relatives from trading in the company's shares during this period. The date of the board meeting to approve Q3 results will be communicated separately. The intimation was signed by Managing Director Brahma Gurbani on 29 December 2025.
This is a routine compliance announcement and does not signal any material change for shareholders. Investors should note that the upcoming Q3 results announcement will be a potential catalyst for stock movement once the trading window reopens.